THE ROYAL AUSTRALIAN AND NEW ZEALAND COLLEGE OF PSYCHIATRISTS. Clinical Memorandum #18 TRANSCRANIAL MAGNETIC STIMULATION
|
|
- Jennifer Campbell
- 7 years ago
- Views:
Transcription
1 Clinical Memorandum #18 Page 1 THE ROYAL AUSTRALIAN AND NEW ZEALAND COLLEGE OF PSYCHIATRISTS Clinical Memorandum #18 TRANSCRANIAL MAGNETIC STIMULATION 1. INTRODUCTION Subconvulsive repetitive transcranial magnetic stimulation (rtms) is being developed as a psychiatric treatment. Its therapeutic potential in psychiatry is being studied in many countries throughout the world, including Australia. It involves the focal application of magnetic energy to the cerebral cortex, inducing small electrical currents which may alter brain functioning with therapeutic effect and without loss of consciousness, loss of memory, or seizure. Research has examined the physiological processes by which rtms is considered to exert its effects. Reports have generated positive views about its likely efficacy and usefulness in the treatment of Major Depressive Disorder and its use is being researched in other psychiatric conditions (Fitzgerald, Brown, & Daskalakis, 2002). 2. EVIDENCE FOR EFFICACY OF rtms IN DEPRESSION 2.1 Many clinical trials, including sham controlled trials, have been conducted worldwide to assess the antidepressant activity of rtms. Although treatment protocols have differed with respect to stimulus parameters and site of stimulation, the majority of trials have reported antidepressant efficacy for rtms, particularly for high frequency rtms to the left prefrontal cortex. Meta-analyses of these trials have confirmed clear statistical evidence for the superiority of rtms over a sham control in treating depression, though the magnitude of change in some trials has been of questionable clinical significance (Mitchell & Loo, 2006). 2.2 The efficacy of rtms in earlier studies may have been compromised by suboptimal treatment paradigms, in particular, limiting the rtms course to a two-week period. For high frequency left prefrontal stimulation (the form of rtms for which there is most evidence), recent studies have suggested that extending the treatment course to four to six weeks may be beneficial. In the most definitive trial of rtms in depression to date, over 300 medication refractory subjects received rtms or a sham control over a sixweek period, with relatively intense stimulation parameters (intensity and number of stimuli). This study confirmed the superiority of high frequency left prefrontal rtms over a sham control, but did not produce clinical benefits of greater magnitude than that seen in earlier studies (O Reardon et al., 2007). 2.3 The optimal rtms stimulation parameters for efficacy (such as the number, intensity, frequency, and waveform of stimuli, the number and spacing of stimulation sessions, the alteration of parameters over the course of rtms, and the combinations of stimulation parameters and site) are the subject of ongoing research. In addition, knowledge of predictors of response and patient populations most likely to benefit from rtms treatment is evolving, with suggestions that older patients, those with psychotic features, and those who are more treatment resistant are less likely to respond to rtms (Fregni et al, 2005).
2 Clinical Memorandum #18 Page 2 3. SAFETY OF rtms The safety and side effects of rtms have been extensively studied. Seizures are not common but may occur, particularly when rtms is given at high intensity and at high frequencies. Guidelines for safe stimulation parameters have been published (Wassermann, 1998), though seizures may still occur within these stimulation limits (Loo, McFarquhar, & Mitchell, in press). Caution therefore continues to be necessary, with careful screening of subjects for seizure risk factors, and provision for the management of seizures at sites where rtms is given. The only common side effects are local discomfort at the site of coil application and mild headache. There is no evidence at this stage of any adverse effects on memory or other cognitive functions. Temporary hearing loss is a potential side effect which can usually be prevented by the use of earplugs. There have been reports of the induction of mania in bipolar patients, and a case report suggestive of the induction of delusions (Loo et al., in press). 4. INDICATIONS FOR rtms A thorough psychiatric assessment should be undertaken in order to confirm the diagnosis and identify other comorbid factors. On the basis of currently available data, it can be concluded that rtms has antidepressant efficacy which may be clinically significant in a subgroup of depressed patients. Further studies are required to explore the question of the robustness of the clinical response, to identify those patients who are most likely to respond, and to optimise stimulation protocols. Given its favourable safety profile, it is reasonable therefore to recommend that rtms should be available to certain patients in the clinical setting, outside of research, subject to the conditions outlined below ( ): 4.1 Patients for whom rtms might be offered outside a research protocol include: a) those suffering from Major Depressive Disorder (DSM-IV-TR) who have failed or who are intolerant of other suitable treatments; and b) previous responders to rtms who have relapsed. 4.2 In deciding whether to give rtms to patients with a history of epilepsy or with surgically implanted metal in the head, a careful assessment of specific risk should be made. Relative benefits and risks of rtms should be considered and discussed with the patient. Additional precautions may also be necessary (for example, adjustment of medications, or consultation with a neurologist). 4.3 In view of the paucity of evidence on the safety of rtms in pregnancy, pregnant women should not have rtms outside of a properly conducted and ethically approved clinical trial. 4.4 In view of the paucity of information relating to the use of rtms in patients under the age of 18, rtms should only be used outside of an ethically approved clinical trial after careful evaluation of the individual situation by an appropriate child and adolescent psychiatric service. 4.5 Until further data are available, for psychiatric illnesses other than depression, rtms should only be used within an approved research protocol.
3 Clinical Memorandum #18 Page 3 5. TREATMENT PROCEDURE 5.1 Location and Equipment Minimum safety equipment The patient having rtms should be directly observed during stimulation and be appropriately monitored after the procedure, until the responsible clinician has judged that the patient is fit for discharge from the rtms suite. The following equipment should be within easy access for the conduct of every treatment with rtms: oxygen supply; suction apparatus; airway tubes, masks and bag for artificial respiration; intravenous access equipment; and drugs for the management of seizures. The ready availability of support staff for managing a complication should be ensured. Each practitioner of rtms should be familiar with the use of this equipment rtms device The device with which rtms is delivered should be one that is specific for this purpose. It should be approved by local regulatory authorities, serviced and maintained in proper working order, and in accord with the manufacturer s recommendations. Every rtms practitioner should have a sound working knowledge of the device. 5.2 Protocol for treatment A written protocol for the conduct of rtms should be developed. It should specify the following as a minimum: the site(s) of coil placement that will be used and how this will be located on the scalp; the procedure for determining motor threshold, and from this the dose for stimulation; the stimulation parameters and the frequency of treatments; the procedure for protecting against hearing loss; the procedure for managing a seizure; and the frequency of, and the person(s) responsible for, checking the working order of the rtms device and of the necessary safety equipment; and the conditions under which the stimulation will be varied. 6. CONSENT FOR rtms Informed consent should be obtained from the patient by the prescribing psychiatrist. The consent process should detail alternative treatment considerations, the possible benefits of rtms, the side effects and adverse events, including the possibility of seizures and the induction of mania.
4 Clinical Memorandum #18 Page 4 7. EDUCATION AND TRAINING 7.1 In the treatment of depression and other psychiatric disorders, rtms is considered to be a medical procedure and should be prescribed by a psychiatrist and administered by appropriately trained clinical staff who are under the supervision of a medical practitioner. 7.2 Those who are intending to administer rtms should be properly trained in the theory and technique of the treatment and the safe operation of rtms devices. Training should also include the management of resuscitation and of unexpected complications (for example, a seizure). 8. QUALITY AND CREDENTIALING 8.1 It is recommended that rtms should not be an office based procedure. It should be performed in a setting such as a hospital with appropriate trained clinical staff and well maintained rtms machine and ancillary equipment to support the procedure. 8.2 The protocol for rtms practice should be approved by an appropriate local body such as a Medical Advisory Committee or Ethics Committee or similar. 8.3 Each institution that conducts rtms outside a research setting should have in place a formal process which oversees the availability and practice of rtms, the review of treatments including outcomes and complications, the monitoring of clinical indicators, the training of practitioners, and the establishment of a credentialing practice. 9. REFERENCES Eranti, S., Mogg, A., Pluck, G., Landau, S., Purvis, R., Brown, R. G., et al. (2007). A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. American Journal of Psychiatry, 164, Fitzgerald, P., Brown, T., & Daskalakis, Z. (2002). The application of transcranial magnetic stimulation in psychiatry and neurosciences research. Acta Psychiatrica Scandinavica, 105, Fregni, F., Marcolin, M., Myczkowski, M., et al. (2005). Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. International Journal of Neuropsychopharmacology, 9, Loo, C. K., McFarquhar, T., & Mitchell, P. (in press). A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. International Journal of Neuropsychopharmacology. Martin, J. L. R., Barbanoj-Rodriguez, M., Schlaepfer, T., Clos, S., Perez, V., Kulisevsky, J., & Gironell, A. (2003). Transcranial magnetic stimulation for treating depression (Cochrane Review). In The Cochrane Library, Issue 1, Oxford: Update Software. Mitchell, P. B., & Loo, C. K. (2006). Transcranial magnetic stimulation for depression. Australian and New Zealand Journal of Psychiatry, 40, O Reardon, J. P., Solvason, H. B., Janicak, P. G., Sampson, S., Isenberg, K. E., Nahas, Z., et al. (2007). Efficacy and safety of transcranial magnetic stimulation therapy in the acute
5 Clinical Memorandum #18 Page 5 treatment of major depression: A multi-site randomized controlled trial. Biological Psychiatry (in press, e pub 13 June 2007). Wasserman, E. (1998). Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop in the Safety of Repetitive Transcranial Magnetic Stimulation. Electroencephalography and Clinical Neurophysiology, 108, 1-16.
NeuroStar TMS Therapy Patient Guide for Treating Depression
NeuroStar TMS Therapy Patient Guide for Treating Depression This NeuroStar TMS Therapy Patient Guide for Treating Depression provides important safety and use information for you to consider about treating
More informationStep 4: Complex and severe depression in adults
Step 4: Complex and severe depression in adults A NICE pathway brings together all NICE guidance, quality standards and materials to support implementation on a specific topic area. The pathways are interactive
More informationTherapies for Treatment- Resistant Depression. A Review of the Research
Therapies for Treatment- Resistant Depression A Review of the Research Is This Information Right for Me or Someone I Care For? Yes, if: A doctor or health care professional has told you that you have major
More informationHigh-Dose TMS May Rapidly Reduce Suicidal Thoughts
High-Dose TMS May Rapidly Reduce Suicidal Thoughts Deborah Brauser June 10, 2014 Repetitive high-dose transcranial magnetic stimulation (rtms) is safe and rapidly decreases suicidal thoughts, new research
More informationTHE DEPRESSION RESEARCH CLINIC Department of Psychiatry and Behavioral Sciences Stanford University, School of Medicine
THE DEPRESSION RESEARCH CLINIC Department of Psychiatry and Behavioral Sciences Stanford University, School of Medicine Volume 1, Issue 1 August 2007 The Depression Research Clinic at Stanford University
More informationMOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines
MOH CLINICL PRCTICE GUIELINES 2/2008 Prescribing of Benzodiazepines College of Family Physicians, Singapore cademy of Medicine, Singapore Executive summary of recommendations etails of recommendations
More informationAlfredo Velez, M.D. ECT: A REVIEW
Alfredo Velez, M.D. ECT: A REVIEW ECT is not a treatment of last resort!!! History Experiments with medical electricity begin in 18 th Century (!) 1934 Chemical convulsive therapy, camphor, metrazole Hungarian
More informationRepetitive Transcranial Magnetic Stimulation for Treatment Resistant Depression
Repetitive Transcranial Magnetic Stimulation for Treatment Resistant Depression A Health Technology Assessment The Health Technology Assessment Unit, University of Calgary August 6, 2014 1 Acknowledgements
More informationRepetitive Transcranial Magnetic Stimulation for Treatment. Resistant Depression
TITLE: Repetitive Transcranial Magnetic Stimulation for Treatment Resistant Depression AUTHORS: Jeffrey A. Tice M.D. Assistant Professor of Medicine Mitchell D. Feldman, M.D., MPhil. Professor of Medicine
More informationWorking Together for Better Mental Health
Working Together for Better Mental Health One in five Australian adults experience some form of mental illness each year. It can affect people of all ages and from all walks of life. The causes may be
More informationTHE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES
THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES PURPOSE: The goal of this document is to describe the
More informationCRITERIA FOR DIAGNOSIS AND MANAGEMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN ADULTS
CRITERIA FOR DIAGNOSIS AND MANAGEMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN ADULTS For the purpose of this document adults are considered to be persons who are 18 years or over. Separate criteria
More informationElectroconvulsive Therapy - ECT
Electroconvulsive Therapy - ECT Introduction Electroconvulsive therapy, or ECT, is a safe and effective treatment that may reduce symptoms related to depression or mental illness. During ECT, certain parts
More informationELECTROCONVULSIVE THERAPY TODAY
ELECTROCONVULSIVE THERAPY TODAY Irving M. Reti, M.B.B.S., is the director of the Electroconvulsive Therapy Service at The Johns Hopkins Hospital and an assistant professor in the Department of Psychiatry
More informationDEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource
E-Resource March, 2015 DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource Depression affects approximately 20% of the general population
More informationThere are four groups of medications most likely to be used for depression: Antidepressants Antipsychotics Mood stabilisers Augmenting agents.
What this fact sheet covers: Physical treatments (medication, ECT and TMS) Psychological treatments Self-help & alternative therapies Key points to remember Where to get more information. Introduction
More informationPreferred Practice Guidelines Bipolar Disorder in Children and Adolescents
These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder,
More informationElectroconvulsive Therapy (ECT)
Electroconvulsive Therapy (ECT) What is ECT? Electroconvulsive therapy (ECT) is a physical therapy in which a patient under general anesthetic will have an electrical current passed through his or her
More informationDEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE
1 DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE ASSESSMENT/PROBLEM RECOGNITION 1. Did the staff and physician seek and document risk factors for depression and any history of depression? 2. Did staff
More informationFax # s for CAMH programs and services
INFORMATION AND INSTRUCTIONS STEP 1 BEFORE COMPLETING THE REFERRAL FORM CATS Program / General Psychiatry Memory Clinic, Geriatric Mental Health Program Go to www.camh.net for detailed information on each
More informationObsessive Compulsive Disorder: a pharmacological treatment approach
Obsessive Compulsive Disorder: a pharmacological treatment approach Professor Alasdair Vance Head, Academic Child Psychiatry Department of Paediatrics University of Melbourne Royal Children s Hospital
More informationTREATING MAJOR DEPRESSIVE DISORDER
TREATING MAJOR DEPRESSIVE DISORDER A Quick Reference Guide Based on Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition, originally published in April 2000.
More informationNoninvasive Neuromodulation in Psychiatric Treatment: Current and Developing
Noninvasive Neuromodulation in Psychiatric Treatment: Current and Developing Sarah H. Lisanby, MD J.P. Gibbons Professor and Chair Psychiatry & Behavioral Sciences ECT TMS dtms Benefits Risks Critical
More information*Reflex withdrawal from a painful stimulus is NOT considered a purposeful response.
Analgesia and Moderate Sedation This Nebraska Board of Nursing advisory opinion is issued in accordance with Nebraska Revised Statute (NRS) 71-1,132.11(2). As such, this advisory opinion is for informational
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines - 2015
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More informationAlgorithm for Initiating Antidepressant Therapy in Depression
Algorithm for Initiating Antidepressant Therapy in Depression Refer for psychotherapy if patient preference or add cognitive behavioural office skills to antidepressant medication Moderate to Severe depression
More informationTreatments for Major Depression. Drug Treatments The two (2) classes of drugs that are typical antidepressants are:
Treatments for Major Depression Drug Treatments The two (2) classes of drugs that are typical antidepressants are: 1. 2. These 2 classes of drugs increase the amount of monoamine neurotransmitters through
More informationACUTE TREATMENT SERVICES (ATS) FOR SUBSTANCE USE DISORDERS LEVEL III.7
ACUTE TREATMENT SERVICES (ATS) FOR SUBSTANCE USE DISORDERS LEVEL III.7 Providers contracted for this level of care or service are expected to comply with all requirements of these service-specific performance
More informationConjoint Professor Brian Draper
Chronic Serious Mental Illness and Dementia Optimising Quality Care Psychiatry Conjoint Professor Brian Draper Academic Dept. for Old Age Psychiatry, Prince of Wales Hospital, Randwick Cognitive Course
More informationObjectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.
Addiction Psychiatry Program Site Specific Goals and Objectives Addiction Psychiatry (ADTU) Goal: By the end of the rotation fellow will acquire the knowledge, skills and attitudes required to recognize
More informationKENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE
KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE 201 KAR 9:260. Professional standards for prescribing and dispensing controlled substances.
More informationHow To Know If You Can Get Help For An Addiction
2014 FLORIDA SUBSTANCE ABUSE LEVEL OF CARE CLINICAL CRITERIA SUBSTANCE ABUSE LEVEL OF CARE CLINICAL CRITERIA Overview Psychcare strives to provide quality care in the least restrictive environment. An
More informationProfessional Practice Medical Record Documentation Guidelines
Professional Practice Medical Record Documentation Guidelines INTRODUCTION Consistent and complete documentation in the medical record is an essential component of quality patient care. All Participating
More informationLEVETIRACETAM MONOTHERAPY
LEVETIRACETAM MONOTHERAPY Beth Korby, RN C Patricia E. Penovich, MD John R. Gates, MD Deanna L. Dickens, MD Gerald L. Moriarty, MD This paper has been prepared specifically for: American Epilepsy Society
More informationCommunity Center Readiness Guide Additional Resource #17 Protocol for Physician Assistants and Advanced Practice Nurses
Community Center Readiness Guide Additional Resource #17 Protocol for Physician Assistants and Advanced Practice Nurses PROTOCOL FOR PHYSICIAN ASSISTANTS AND ADVANCED PRACTICE NURSES 1. POLICY Advanced
More informationDepression is a common biological brain disorder and occurs in 7-12% of all individuals over
Depression is a common biological brain disorder and occurs in 7-12% of all individuals over the age of 65. Specific groups have a much higher rate of depression including the seriously medically ill (20-40%),
More informationSee also www.thiswayup.org.au/clinic for an online treatment course.
Depression What is depression? Depression is one of the common human emotional states. It is common to experience feelings of sadness and tiredness in response to life events, such as losses or disappointments.
More informationMedical Necessity Criteria
Medical Necessity Criteria 2015 Updated 03/04/2015 Appendix B Medical Necessity Criteria Purpose: In order to promote consistent utilization management decisions, all utilization and care management staff
More informationTowards Developing a Manual for Residential Treatment Centers to Support Individuals with an FASD and Their Families
Towards Developing a Manual for Residential Treatment Centers to Support Individuals with an FASD and Their Families Presented By Dr. Pamela Gillen University of Colorado Anschutz Medical Campus and Dan
More informationMOH CLINICAL PRACTICE GUIDELINES 6/2011 DEPRESSION
MOH CLINICAL PRACTICE GUIDELINES 6/2011 DEPRESSION Executive summary of recommendations Details of recommendations can be found in the main text at the pages indicated. Clinical evaluation D The basic
More informationPlain Language. Guide
Plain Language Guide Mental Health Act 2009 Disclaimer The information contained in this publication is intended to assist in the interpretation of the Mental Health Act 2009 and is not a substitute for
More informationSUMMARY OF THE BROAD PURPOSE OF THE POSITION AND ITS RESPONSIBILITIES / DUTIES
POSITION DESCRIPTION Credentialled Mental Health Nurse (CMHN) Contractor SUMMARY OF THE BROAD PURPOSE OF THE POSITION AND ITS RESPONSIBILITIES / DUTIES As a contractor to Summit Health s mental health
More informationRecognizing and Treating Depression in Children and Adolescents.
Recognizing and Treating Depression in Children and Adolescents. KAREN KANDO, MD Division of Child and Adolescent Psychiatry Center for Neuroscience and Behavioral Medicine Phoenix Children s Hospital
More informationAppendix D. Behavioral Health Partnership. Adolescent/Adult Substance Abuse Guidelines
Appendix D Behavioral Health Partnership Adolescent/Adult Substance Abuse Guidelines Handbook for Providers 92 ASAM CRITERIA The CT BHP utilizes the ASAM PPC-2R criteria for rendering decisions regarding
More informationWORKERS COMPENSATION PROTOCOLS WHEN PRIMARY INJURY IS PSYCHIATRIC/PSYCHOLOGICAL
WORKERS COMPENSATION PROTOCOLS WHEN PRIMARY INJURY IS PSYCHIATRIC/PSYCHOLOGICAL General Guidelines for Treatment of Compensable Injuries Patient must have a diagnosed mental illness as defined by DSM-5
More informationNew York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery
New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery USING THE 48 HOUR OBSERVATION BED USING THE 48 HOUR OBSERVATION BED Detoxification
More informationSUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D]
SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D] I. Definitions: Detoxification is the process of interrupting the momentum of compulsive drug and/or alcohol use in an individual
More informationMedications for bipolar disorder
Medications for bipolar disorder Findings from Australian National Survey of Mental Health and Wellbeing (Mitchell et al, 2004) In 12 months, only one-third saw a mental health professional 40% received
More informationSchizoaffective Disorder
FACT SHEET 10 What Is? Schizoaffective disorder is a psychiatric disorder that affects about 0.5 percent of the population (one person in every two hundred). Similar to schizophrenia, this disorder is
More informationDepression in Older Persons
Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression
More information2012 Global Neuro-psychiatric Devices New Product Innovation Award
2012 Global Neuro-psychiatric Devices New Product Innovation Award Frost & Sullivan s Global Research Platform Frost & Sullivan has over 50 years of expertise in business with a global research organization
More informationCorporate Medical Policy
Corporate Medical Policy Quantitative Electroencephalography as a Diagnostic Aid for Attention File Name: Origination: Last CAP Review: Next CAP Review: Last Review: quantitative_electroencephalography_as_a_diagnostic_aid_for_adhd
More informationMOLINA HEALTHCARE OF CALIFORNIA
MOLINA HEALTHCARE OF CALIFORNIA MAJOR DEPRESSION IN ADULTS IN PRIMARY CARE HEALTH CARE GUIDELINE (ICSI) Health Care Guideline Twelfth Edition May 2009. The guideline was reviewed and adopted by the Molina
More informationClinical Practice Guidelines: Attention Deficit/Hyperactivity Disorder
Clinical Practice Guidelines: Attention Deficit/Hyperactivity Disorder AACAP Official Action: OUTLINE OF PRACTICE PARAMETERS FOR THE ASSESSMENT AND TREATMENT OF CHILDREN, ADOLESCENTS, AND ADULTS WITH ADHD
More informationVNS Therapy for Epilepsy
VNS Therapy for Epilepsy This pamphlet provides general information for the public. It is not intended to cover all possible uses, directions, precautions, interactions or adverse effects involving any
More informationFlorida Medicaid: Mental Health and Substance Abuse Services
Florida Medicaid: Mental Health and Substance Abuse Services Beth Kidder Assistant Deputy Secretary for Medicaid Operations Agency for Health Care Administration House Children, Families, and Seniors Subcommittee
More informationMedical Policy Manual. Topic: Transcranial Magnetic Stimulation as a Treatment of Depression and Other Disorders. Date of Origin: April 2, 2002
Medical Policy Manual Topic: Transcranial Magnetic Stimulation as a Treatment of Depression and Other Disorders Date of Origin: April 2, 2002 Section: Medicine Approved Date: February 2016 Policy No: 148
More informationPATIENT INFORMATION SHEET KEY FACTS
PATIENT INFORMATION SHEET KEY FACTS Please read this carefully and refer to the full information sheet You are invited to take part in a research study, comparing subcutaneously (injection under skin)
More informationAddiction Psychiatry Fellowship Rotation Goals & Objectives
Addiction Psychiatry Fellowship Rotation Goals & Objectives Table of Contents University Neuropsychiatric Institute (UNI) Training Site 2 Inpatient addiction psychiatry rotation.....2 Outpatient addiction
More informationALLOW NATURAL DEATH/WITHHOLDING AND/OR WITHDRAWING L I F E - S U S T A I N I N G T R E A T M E N T / NON-BENEFICIAL CARE AND RESUSCITATION POLICY
PURPOSE SUPPORTIVE DATA To specify the parameters within which decisions regarding the withholding and/or withdrawing of life-sustaining treatment/non beneficial care and/or no initiation of cardiopulmonary
More informationScreening Tools and Interventions for Common Behavioral Health Disorders TXPEC-0772-13
Screening Tools and Interventions for Common Behavioral Health Disorders TXPEC-0772-13 Screening Tools and Interventions for Common Behavioral Health Disorders Depression Depression is a potentially life-threatening
More informationTop Peer Reviewed Journals Psychiatry & Psychology
Top Peer Reviewed Journals Psychiatry & Psychology Presented to Iowa State University Presented by Thomson Reuters Psychiatry & Psychology The subject discipline for Psychiatry & Psychology is made of
More informationin young people Management of depression in primary care Key recommendations: 1 Management
Management of depression in young people in primary care Key recommendations: 1 Management A young person with mild or moderate depression should typically be managed within primary care services A strength-based
More informationBest Practices Treatment Guideline for Major Depression
Best Practices Treatment Guideline for Major Depression Special Report on New Depression Treatment Technology Based on 2010 APA Practice Guidelines Best Practices Guideline for the Treatment of Patients
More informationClinical Criteria 4.201 Inpatient Medical Withdrawal Management 4.201 Substance Use Inpatient Withdrawal Management (Adults and Adolescents)
4.201 Inpatient Medical Withdrawal Management 4.201 Substance Use Inpatient Withdrawal Management (Adults and Adolescents) Description of Services: Inpatient withdrawal management is comprised of services
More informationD. Clinical indicators for psychiatric evaluation are established by one or more of the following criteria. The consumer is:
MCCMH MCO Policy 2-015 Date: 4/21/11 V. Standards A. A psychiatric evaluation shall be done as an integral part of the assessment process. It serves as the guide to the identification of medical and psychiatric
More informationMental Health Nurse Incentive Program Program Guidelines
Mental Health Nurse Incentive Program Program Guidelines 1 Introduction On 5 April 2006, the Prime Minister announced the Australian Government would provide funding of $1.9 billion over five years for
More informationTable of Contents. Preface...xv. Part I: Introduction to Mental Health Disorders and Depression
Table of Contents Visit www.healthreferenceseries.com to view A Contents Guide to the Health Reference Series, a listing of more than 16,000 topics and the volumes in which they are covered. Preface...xv
More informationOCCUPATIONAL GROUP: Health Services. CLASS FAMILY: Nursing CLASS FAMILY DESCRIPTION:
OCCUPATIONAL GROUP: Health Services CLASS FAMILY: Nursing CLASS FAMILY DESCRIPTION: This family of positions includes those whose purpose is to perform professional nursing services that directly and/or
More informationThe New England Comparative Effectiveness Public Advisory Council. Public Meeting December 9, 2011
The New England Comparative Effectiveness Public Advisory Council Public Meeting December 9, 2011 Nonpharmacologic Interventions for Treatment-Resistant Depression: Supplementary Data and Analyses to the
More informationName of Policy: Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric Disorders
Name of Policy: Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric Disorders Policy #: 170 Latest Review Date: December 2014 Category: Medicine Policy Grade: A Background/Definitions:
More informationThe Diagnostic field. Functions (specialised levels)
Job description: Consultant in psychiatry combined with Clinical professor and Chair. Department for Depression and Anxiety, Aarhus University Hospital Risskov, Denmark. A position as Consultant in psychiatry
More informationIN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA UNITED STATES OF AMERICA : CRIMINAL NO. v.
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA UNITED STATES OF AMERICA : CRIMINAL NO. v. : DATE FILED: NOVARTIS PHARMACEUTICALS : VIOLATION: CORPORATION 21 U.S.C. 331(a),
More information4.401 Substance Use Partial Hospitalization Program (Adults and Adolescents)
4.40 STRUCTURED DAY TREATMENT SERVICES 4.401 Substance Use Partial Hospitalization Program (Adults and Adolescents) Description of Services: Substance use partial hospitalization is a nonresidential treatment
More informationPsychotic Disorders. 1995-2013, The Patient Education Institute, Inc. www.x-plain.com mhff0101 Last reviewed: 01/10/2013 1
Psychotic Disorders Introduction Psychotic disorders are severe mental disorders that cause abnormal thinking and perceptions. These disorders cause people to lose touch with reality. As a result, people
More informationOur faculty has been hand-picked for their knowledge, experience, and enthusiasm for teaching
We welcome your interest in Advocate Lutheran General Hospital s Psychiatry Residency Program. ALGH is a 638-bed teaching hospital located adjacent to Chicago on the northwest side. We proudly provide
More informationNew Patient Information. Address: City: State: Zip: Ph#: Cell#:
Patient Information: Last Name: New Patient Information First Name: Address: City: State: Zip: Ph#: Cell#: S.S.N: Email: May we contact you by email? Yes No Date of Birth: May we send you information about
More informationGeneral Hospital Information
Inpatient Programs General Hospital Information General Information The Melbourne Clinic is a purpose built psychiatric hospital established in 1975, intially privately owned by a group of psychiatrists
More informationAmerican Society of Addiction Medicine
American Society of Addiction Medicine Public Policy Statement on Treatment for Alcohol and Other Drug Addiction 1 I. General Definitions of Addiction Treatment Addiction Treatment is the use of any planned,
More informationPatients with dementia and other types of structural brain injury are predisposed to delirium (i.e., abrupt onset, temporary confusion caused by
Dementia is the permanent loss of multiple intellectual functions resulting from neuronal death. Dementia afflicts 10% of individuals over the age of 65 and these patients survive approximately seven years
More informationtreatment effectiveness and, in most instances, to result in successful treatment outcomes.
Key Elements of Treatment Planning for Clients with Co Occurring Substance Abuse and Mental Health Disorders (COD) [Treatment Improvement Protocol, TIP 42: SAMHSA/CSAT] For purposes of this TIP, co occurring
More informationNATIONAL COMPETENCY SKILL STANDARDS FOR PERFORMING AN ELECTROENCEPHALOGRAM
NATIONAL COMPETENCY SKILL STANDARDS FOR PERFORMING AN ELECTROENCEPHALOGRAM Electroencephalographic (EEG) providers practice in accordance with the facility policy and procedure manual which details every
More informationContents. Overview Treatments Inpatient Services Day Programs The Clinic What are the Costs? How to Get Started How to Find Us
Lakeside Clinic Contents Overview Treatments Inpatient Services Day Programs The Clinic What are the Costs? How to Get Started How to Find Us Overview At some point in their lives, as many as one-in-five
More informationBehavioral Health Medical Necessity Criteria
Behavioral Health Medical Necessity Criteria Revised: 7/14/05 2 nd Revision: 9/14/06 3 rd Revision: 8/23/07 4 th Revision: 8/28/08; 11/20/08 5 th Revision: 8/27/09 Anthem Blue Cross and Blue Shield 2 Gannett
More informationMajor Depressive Disorders Questions submitted for consideration by workshop participants
Major Depressive Disorders Questions submitted for consideration by workshop participants Prioritizing Comparative Effectiveness Research Questions: PCORI Stakeholder Workshops June 9, 2015 Patient-Centered
More informationRULES OF THE TENNESSEE DEPARTMENT OF MENTAL HEALTH AND DEVELOPMENTAL DISABILITIES
RULES OF THE TENNESSEE DEPARTMENT OF MENTAL HEALTH AND DEVELOPMENTAL DISABILITIES CHAPTER 0940-05-47 MINIMUM PROGRAM REQUIREMENTS FOR ALCOHOL AND DRUG OUTPATIENT DETOXIFICATION TREATMENT FACILITIES TABLE
More informationMental Health Act 2009
Version: 29.3.2015 South Australia Mental Health Act 2009 An Act to make provision for the treatment, care and rehabilitation of persons with serious mental illness with the goal of bringing about their
More informationPractice Guidelines. Professional Practice Medical Record Documentation Guidelines
Practice Guidelines 2010 Professional Practice Medical Record Documentation Guidelines Health care benefit programs issued or administered by Capital BlueCross and/or its subsidiaries, Capital Advantage
More informationParent s Guide to Choosing a Teen Treatment Center. Questions parents should think about before selecting a teen rehab
Parent s Parent s Guide to Guide Choosing to Choosing a Teen a Teen Questions parents should think about before selecting a teen rehab Parent s Parent s Guide to Guide Choosing to Choosing a Teen a Teen
More informationPresently, there are no means of preventing bipolar disorder. However, there are ways of preventing future episodes: 1
What is bipolar disorder? There are two main types of bipolar illness: bipolar I and bipolar II. In bipolar I, the symptoms include at least one lifetime episode of mania a period of unusually elevated
More informationSPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT ALCOHOL MISUSE
SPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT OF ALCOHOL MISUSE Date: March 2015 1 1. Introduction Alcohol misuse is a major public health problem in Camden with high rates of hospital
More informationGood Morning, Welcome!
Good Morning, Welcome! The Treatment Record Review presentation will begin shortly. This presentation will be recorded and available on MagellanofVirginia.com Questions may be asked following the presentation,
More informationA NEW, NON-DRUG APPROACH TO TREATING DEPRESSION. www.nexstim.com
A NEW, NON-DRUG APPROACH TO TREATING DEPRESSION 2 Depression A large and growing challenge in society Numerous studies over the past decade have revealed the true extent and devastating impact of depression.
More informationUpdate on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice
Update on guidelines on biological treatment of depressive disorder Dr. Henry CHEUNG Psychiatrist in private practice 2013 update International Task Force of World Federation of Societies of Biological
More informationUniversity of Hawai i Human Studies Program. Guidelines for Developing a Clinical Research Protocol
University of Hawai i Human Studies Program Guidelines for Developing a Clinical Research Protocol Following are guidelines for writing a clinical research protocol for submission to the University of
More informationHow To Treat A Drug Addiction
1 About drugs Drugs are substances that change a person s physical or mental state. The vast majority of drugs are used to treat medical conditions, both physical and mental. Some, however, are used outside
More informationMental Health Nurse Incentive Program
An Australian Government Initiative Mental Health Nurse Incentive Program A program to enable psychiatrists general practitioners to engage mental health nurses Program Guidelines 1 Introduction The Mental
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Sedation for diagnostic and therapeutic procedures in children and young people 1.1 Short title Sedation in children and young
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS IN THE TREATMENT OF DEPRESSION
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 25 April 2002 CPMP/EWP/518/97, Rev. 1 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE
More informationSPECIALIZED PHYSICAL HEALTH CARE SERVICES. RECTAL DIAZEPAM ADMINISTRATION (DIASTAT or DIASTAT AcuDial )
SAN DIEGO UNIFIED SCHOOL DISTRICT Nursing & Wellness Program SPECIALIZED PHYSICAL HEALTH CARE SERVICES RECTAL DIAZEPAM ADMINISTRATION (DIASTAT or DIASTAT AcuDial ) THIS PROCEDURE SHALL BE PERFORMED BY
More information